Responses
Clinical and epidemiological research
Extended report
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
Compose a Response to This Article
Other responses
No responses have been published for this article.